SEMABIZ, Inc.

合成生物学市場 – 2029年までの世界予測

Synthetic Biology Market – Global Forecast to 2029

合成生物学市場 – ツール (オリゴヌクレオチド、酵素、合成細胞)、テクノロジー (配列決定、バイオインフォマティクス)、用途 (創薬、組織再生、バイオ燃料、食品、農業、消費者ケア、環境) – 2029年までの世界予測
Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Sequencing, Bioinformatics), Applications (Drug Discovery, Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental) – Global Forecast to 2029

The global synthetic biology market is projected to surpass USD 31.52 billion in 2029 from USD 12.33 billion in 2024, with a significant CAGR of 20.6%.

世界の合成生物学市場は、2024年の123億3,000万米ドルから2029年には315億2,000万米ドルを超え、20.6%という大幅なCAGRで成長すると予測されています。

合成生物学市場 – 2029年までの世界予測
synthetic-biology-market-Ecosystem

Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), Novozymes A/S (Denmark), Agilent Technologies Inc. (US), Eurofins Scientific (Luxembourg), Amyris, Inc. (US), Twist Bioscience (US), Codexis, Inc. (US), Genscript (US), Ginkgo Bioworks (US), Precigen (US), Creative Enzymes (US), Synthego (US), Viridos (US), and Cyrus Biotechnology (US)  are some of the major players operating in the synthetic biology market.

The report provides insights on the following pointers:

  • Analysis of key drivers (diverse applications of synthetic biology, increasing demand for bio-based products, advancements in synthetic biology, rising funding in R&D and collaborations), restraints (production scalability, ethical and regulatory challenges), opportunities (rising opportunities for agricultural synthetic biology, growing use of artificial intelligence and machine learning) and Challenges (Cost constraints) influencing the growth of the market.
  • Product Development/Innovation: Detailed insights on upcoming technologies in synthetic biology manufacturing, research and development activities, and new product launches in the synthetic biology market.
  • Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the synthetic biology market
  • Competitive Assessment: Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Novozymes A/S (Denmark), Eurofins Scientific (Luxembourg), Agilent Technologies Inc. (US), among others in the market.

バイオ技術の最新記事8件